Saturday, April 6, 2019

Avista Capital Partners Acquires Dermatology Business Unit


Since 2005, Thompson Dean has served as cofounding CEO of Avista Capital Partners, a New York City-based private equity firm focused on investments in growth-oriented health care companies. Some of Thompson Dean and Avista's recent business activities include acquiring the extended topicals and dermatology unit of G&W Laboratories. 

Headquartered in South Plainfield, New Jersey, G&W Laboratories leverages more than 100 years of experience to provide people with a variety of high-quality products. The company's portfolio consists of approximately three dozen topical dermatology products, such as creams, ointments, liquids, and gels.

In partnering with G&W Dermatology, Avista named Walt Kaczmarek, a business executive with over 25 years of pharmaceutical industry experience, to serve as CEO. He is working with G&W's established team to oversee existing and pipeline products as well as the company's research and development and manufacturing capabilities. 

Avista's acquisition of G&W Dermatology does not affect G&W Laboratories' other business activities, including manufacturing operations in Pennsylvania and North Carolina. The Avista portfolio currently comprises over $6 billion of investments in approximately 30 health-oriented businesses.